In Amarin’s pending Hatch-Waxman Vascepa case against Dr. Reddy’s and Hikma, we see at least obstacles to settlement at this time before resolution of the appeal: money, entry and invalidity.
Read More
Patent Valuation, Monetization and Investments
Patent Valuation, Monetization and Investments